Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks is a research paper published in The Journal of Infectious Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Swiss National Science Foundation
Grant: 179571
HIV-1 Transmission in Switzerland: viral transmission traits, superinfection and drug resistance
University of Zurich
Grant: PZ00P3-142411
University of Zurich
Grant: BSSGI0_155851
Swiss National Science Foundation
Grant: 155851
Using transmission networks for assessing and guiding prevention efforts in hiv
Swiss National Science Foundation
Grant: 142411
Combining molecular epidemiology approaches and mathematical models for the spread of HIV and its coinfections
FWCI
1.45
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals